Lipantil 200 M

Lipantil 200 M: Lipid-lowering agent for the control of cholesterol and triglycerides

Lipantil 200 M, also known by the international name Ciprofibrate and synonym Lipanor, is a lipid-lowering agent belonging to the pharmaceutical group of fibrates. It is widely used to control cholesterol and triglyceride levels in the body. Lipantil 200 M is produced by the Fournier laboratory in France.

One of the key features of Lipantil 200 M is its ability to effectively reduce cholesterol and triglyceride levels in the blood. This is especially important for patients with endogenous hypercholesterolemia, when elevated cholesterol levels are the result of metabolic disorders in the body. Lipantil 200 M is also used in cases of hypertriglyceridemia, when the level of triglycerides in the blood exceeds the norm.

The dosage form of Lipantil 200 M is presented in the form of capsules containing 200 mg of the active substance - Ciprofibrate. This ensures ease of administration and dosage of the drug.

However, before starting treatment with Lipantil 200 M, it is necessary to take into account some contraindications. The drug is not recommended in case of hypersensitivity to its components, as well as in the presence of renal or liver failure. Also, its use is not recommended during pregnancy, breastfeeding and in children.

When using Lipantil 200 M, some side effects may occur. These may include headache, nausea, weakness, increased fatigue, as well as muscle pain (myositis, myalgia). In rare cases, exacerbation of cholelithiasis, an increase in the level of serum transaminases, creatinine and the appearance of skin allergic reactions are possible.

It is also necessary to take into account the interaction of Lipantil 200 M with other drugs. It is incompatible with hepatotoxic agents such as perexillite maleate and MAO inhibitors. It also enhances the effect of indirect anticoagulants (antivitamins K). When administered simultaneously with nicotinic acid derivatives and other hypocholesterolemic drugs, higher treatment efficiency can be achieved.

Lipantil 200 M requires special instructions for use. If after 3-6 months of treatment the desired effect is not achieved, it is recommended to reconsider the dosage regimen or consider alternative treatment methods. It is also important to regularly monitor the patient's cholesterol and triglyceride levels.

Overall, Lipantil 200 M is an important drug for controlling cholesterol and triglyceride levels. However, self-medication is not recommended, and before starting to take the drug, you should consult your doctor, who will determine the appropriate dosage and duration of treatment depending on the individual characteristics of the patient.